Checkpoint Inhibitors in Head and Neck Cancer: Rationale, Clinical Activity, and Potential Biomarkers

Panagiota Economopoulou1, Ioannis Kotsantis2, Amanda Psyrri3

  • 1Department of Internal Medicine, Section of Medical Oncology, Attikon University Hospital, National Kapodistrian University of Athens, School of Medicine, 1St Rimini St, 12462, Haidari, Athens, Greece. panagiota_oiko@hotmail.com.

Abstract

Insights

Immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) show promise in cancer treatment. Biomarker development is crucial for selecting head and neck squamous cell carcinoma patients who will benefit from these therapies.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Immune checkpoint inhibitors targeting PD-1 and CTLA-4 pathways have yielded significant anti-cancer outcomes.
  • Approvals in melanoma, non-small cell lung cancer, and renal cell cancer highlight their clinical efficacy.
  • Ongoing research explores PD-1 inhibitors in diverse tumor types and combination therapies.

Purpose of the Study:

  • To evaluate the potential of PD-1 pathway inhibitors in treating head and neck squamous cell carcinoma (HNSCC).
  • To emphasize the critical need for biomarker development in HNSCC for patient selection and trial design.

Main Methods:

  • Review of current clinical data and research on immune checkpoint inhibitors.
  • Analysis of HNSCC characteristics, including its immunosuppressive nature.
  • Discussion of biomarker strategies for patient stratification.

Main Results:

  • PD-1 and CTLA-4 pathway inhibition demonstrates clinical success in various cancers.
  • HNSCC presents a promising, yet challenging, area for immunotherapy investigation due to profound immunosuppression.
  • Biomarker-driven patient selection is essential for maximizing therapeutic benefit.

Conclusions:

  • Immune checkpoint inhibitors are a rapidly advancing frontier in cancer treatment.
  • Targeting PD-1 pathways in HNSCC warrants further investigation, with a focus on identifying responsive patient subsets.
  • Biomarker development is paramount for the successful clinical application of immunotherapy in HNSCC.

Related Concept Videos

Arteries of the Head and Neck01:26

Arteries of the Head and Neck

The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
3.3K
Veins of Head and Neck01:19

Veins of Head and Neck

The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
5.7K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.9K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Thermodynamics: Chemical Potential and Activity01:10

Thermodynamics: Chemical Potential and Activity

The effective concentration of a species in a solution can be expressed precisely in terms of its activity. Activity considers the effect of electrolytes present in the vicinity of the species of interest and depends on the ionic strength of the solution. The activity of a species is expressed as the product of molar concentration and the activity coefficient of the species.
The thermodynamic equilibrium constant is more accurately defined in terms of activity rather than concentration.
1.7K
Muscles of the Anterior Neck01:26

Muscles of the Anterior Neck

The anterior neck muscles are the group of muscles covering the front part of the neck. These muscles are classified into three subgroups. The first one is the superficial muscles, the most visible muscles in the front of the neck. It includes the platysma and sternocleidomastoid. The second group is the suprahyoid muscles, located above the hyoid bone. This group comprises the digastric, mylohyoid, geniohyoid, and stylohyoid. Lastly, the infrahyoid muscles are found below the hyoid bone and...
4.9K